{"transactions":[{"id":730155,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36261,"kind":"person","name":"Su Zhen","position":1,"cik":"0001991642","reported_name":"Su Zhen","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:53:26.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":59000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":59000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":59000},"source":{"system":"sec-edgar","filing":"0001610717-26-000280","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071726000280/form4.xml","form_type":"4"}},{"id":763336,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":36261,"kind":"person","name":"Su Zhen","position":1,"cik":"0001991642","reported_name":"Su Zhen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T20:13:23.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":15508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on May 21, 2027; however, delivery of the shares is deferred until the earlier of (a) the date of the director's separation from service to Karyopharm Therapeutics Inc. and (b) a change-in-control event."}],"balance_after":15508,"source":{"system":"sec-edgar","filing":"0001991642-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000199164226000002/ownership.xml","form_type":"4"}},{"id":1111132,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36261,"kind":"person","name":"Su Zhen","position":1,"cik":"0001991642","reported_name":"Su Zhen","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:19:11.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2026 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":38000,"derivative":{"exercise_price":2.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001610717-25-000215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000215/form4.xml","form_type":"4"}},{"id":1130277,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":36261,"kind":"person","name":"Su Zhen","position":1,"cik":"0001991642","reported_name":"Su Zhen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2025-05-29T20:15:13.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"shares","element":"transactionShares","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 100% of the underlying shares on May 28, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."}],"balance_after":4600,"derivative":{"exercise_price":4.48,"expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0000950170-25-078974","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000095017025078974/ownership.xml","form_type":"4"}},{"id":1497557,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":36261,"kind":"person","name":"Su Zhen","position":1,"cik":"0001991642","reported_name":"Su Zhen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-05-30T21:32:37.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":50587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on May 29, 2025."}],"balance_after":50587,"derivative":{"exercise_price":0.96,"expiration_date":"2034-05-28","underlying":"Common Stock","underlying_shares":50587},"source":{"system":"sec-edgar","filing":"0000950170-24-066787","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000095017024066787/ownership.xml","form_type":"4"}},{"id":1510698,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36261,"kind":"person","name":"Su Zhen","position":1,"cik":"0001991642","reported_name":"Su Zhen","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-17T21:36:07.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":38000,"derivative":{"exercise_price":1.96,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001610717-24-000247","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000247/form4.xml","form_type":"4"}},{"id":1563098,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36261,"kind":"person","name":"Su Zhen","position":1,"cik":"0001991642","reported_name":"Su Zhen","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T20:27:39.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":76000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from March 20, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":76000,"derivative":{"exercise_price":2.27,"expiration_date":"2034-03-19","underlying":"Common Stock","underlying_shares":76000},"source":{"system":"sec-edgar","filing":"0001610717-24-000181","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000181/form4.xml","form_type":"4"}},{"id":1790635,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":36261,"kind":"person","name":"Su Zhen","position":1,"cik":"0001991642","reported_name":"Su Zhen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-09-01T12:20:11.000Z","date":"2023-08-31","kind":"grant","planned":false,"acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 31, 2023.  The shares underlying the option vest as to one-third (1/3) of the shares on August 31, 2024 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter."}],"balance_after":68000,"derivative":{"exercise_price":1.28,"expiration_date":"2033-08-30","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001209191-23-047913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919123047913/doc4.xml","form_type":"4"}}]}